干燥综合征与终生性激素暴露降低相关:病例对照研究
该病例对照研究纳入Sjögren国际协作临床联盟注册库中2680例女性,比较1320例原发性干燥综合征(SS)患者与1360例无SS关键特征的干燥症状对照。校正年龄、招募中心、种族、教育、就业状态和吸烟后,复合雌激素评分(CES)与原发性SS呈进行性负相关趋势,最高CMC水平绝经后组中原发性SS参与者累积性激素暴露较对照降低24%。
要点
- 复合雌激素评分(CES)越高,原发性SS风险越低,呈进行性负相关趋势。
- CES 3相对干燥症状对照的OR为0.50(95%CI 0.30-0.86)。
- 绝经后组最高CMC水平者原发性SS累积性激素暴露较对照降低24%。
核心结论
- 原发性SS女性较干燥症状对照具有更低的雌激素暴露和累积月经周期(CMC)。
- 雌激素暴露增加与原发性SS发生呈负相关。
- 需进一步纵向研究性激素暴露以确认上述发现。
研究设计与样本
- 病例对照研究,纳入Sjögren国际协作临床联盟注册库2680例女性。
- 包括1320例原发性SS注册者和1360例有干燥症状但无原发性SS关键特征的对照。
- CES按初潮早(≤10岁)、高产次(>3次妊娠)、子宫切除、女性激素使用和绝经晚(≥53岁)计分。
- CMC按月经年数减去妊娠时间计算。
- 回归模型校正年龄、招募中心、种族、教育、就业状态和吸烟。
主要发现
- CES与原发性SS呈进行性负相关趋势。
- 相对干燥症状对照:CES 1的OR 0.81(95%CI 0.67-0.99)。
- CES 2的OR 0.74(95%CI 0.57-0.97);CES 3的OR 0.50(95%CI 0.30-0.86)。
- CMC分析佐证CES趋势。
- 绝经后组最高CMC水平者原发性SS参与者累积性激素暴露较对照降低24%。
关键数值与推荐
- CES计分项:初潮早(≤10岁)、高产次(>3次妊娠)、子宫切除、女性激素使用、绝经晚(≥53岁)。
- CMC计算:月经年数减去妊娠时间。
- CES 1的OR 0.81(95%CI 0.67-0.99);CES 2的OR 0.74(95%CI 0.57-0.97);CES 3的OR 0.50(95%CI 0.30-0.86)。
- 绝经后组最高CMC水平者累积性激素暴露降低24%。
临床怎么用
- 对干燥症状女性,评估初潮年龄、产次、子宫切除、激素使用和绝经年龄等性激素暴露因素可能有助于风险分层。
- 原发性SS患者性激素暴露和CMC较低,提示激素因素可能参与发病。
- 目前证据来自病例对照研究,尚不能据此改变临床激素使用建议。
局限性
- 原文仅指出需进一步纵向研究确认发现,未详细列出其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To test whether cumulative estrogen exposure, as determined by age at menarche, age at menopause, female hormone use, hysterectomy, and parity, have an effect on the development of primary Sjögren's syndrome (SS). METHODS: We performed a case-control study of 2,680 women from the Sjögren's International Collaborative Clinical Alliance registry, including 1,320 registrants with primary SS and 1,360 with sicca symptoms but no key features of primary SS (sicca controls). The composite estrogen score (CES) was calculated by point assignment for early menarche (age ≤10 years), high parity (>3 pregnancies), hysterectomy, female hormone use, and late menopause (age ≥53 years). Cumulative menstrual cycling (CMC) was calculated as years menstruating minus time pregnant. RESULTS: Using a regression model that adjusted for age, recruitment site, ethnicity, education, employment status, and smoking, we observed a progressive inverse trend between primary SS and CES. The odds ratio (OR) and 95% confidence interval (95% CI) were as follows for the sicca control group: CES 1, OR 0.81 (95% CI 0.67-0.99); CES 2, OR 0.74 (95% CI 0.57-0.97); CES 3, OR 0.50 (95% CI 0.30-0.86). This trend was corroborated by analysis of CMC. At the highest level of CMC within the postmenopausal group there was a 24% reduction in cumulative sex hormone exposure among primary SS participants relative to controls. CONCLUSION: Women with primary SS have lower estrogen exposure and CMC compared to sicca controls. Increasing estrogen exposure was negatively associated with development of primary SS. Further longitudinal studies of sex hormone exposure in primary SS are needed to confirm these findings.
引用
- McCoy SS, Sampene E, Baer AN, et al. Association of Sjögren's Syndrome With Reduced Lifetime Sex Hormone Exposure: A Case-Control Study. Arthritis Care Res (Hoboken). 2020. PMID: 31233285. doi:10.1002/acr.24014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。